{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:22Z","timestamp":1787021062062,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoarthritis (OA) affects the entire joint, causing structural changes in articular cartilage, subchondral bone, ligaments, capsule, synovial membrane, and periarticular muscles  that afflicts millions of people globally, leading to persistent pain and diminished quality of life. The intra-articular use of platelet-rich plasma (PRP) is gaining recognition as a secure therapeutic approach due to its potential regenerative capabilities. However, there is controversial clinical data regarding efficacy of PRP for OA treatment. In this context, gathering scientific evidence on the effects of PRP in treating OA in animal models could provide valuable insights into understanding its impact on aspects like cartilage health, synovial tissue integrity, and the inflammatory process in affected joints. Thus, the objective of this study was to assess the effects of PRP injections on inflammation and histopathological aspects of cartilage and synovium in animal models of OA through a comprehensive systematic review with meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A electronic search was conducted on Medline, Embase, Web of Science, The Cochrane Library, LILACS, and SciELO databases for relevant articles published until June 2022. A random-effects meta-analysis was employed to synthesize evidence on the histological characteristics of cartilage and synovium, as well as the inflammatory process. The GRADE approach was utilized to categorize the quality of evidence, and methodological quality was assessed using SYRCLE\u2019s RoB tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-one studies were included in the review, with twelve of them incorporated into the meta-analysis. PRP treatment demonstrated superior outcomes compared to the control group in terms of cartilage histology (very low quality;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002), synovium histology (very low quality;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and reductions in proinflammatory markers, including IL-1 (low quality;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), IL-6 (very low quality;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001), and TNF-\u03b1 (very low;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001). However, PRP treatment did not yield a significant impact on PDGF-A levels (very low quality;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.81).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PRP appears capable of reducing proinflammatory markers (IL-1, IL-6, TNF-\u03b1) and mitigating cartilage and synovium damage in animals with OA. However, the levels of evidence of these findings are low to very low. Therefore, more rigorous studies with larger samples are needed to improve the quality of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration<\/jats:title>\n                    <jats:p>CRD42022250314<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-024-00364-0","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T10:01:48Z","timestamp":1711706508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of intra-articular injection of platelet-rich plasma on the inflammatory process and histopathological characteristics of cartilage and synovium in animals with osteoarthritis: a systematic review with meta-analysis"],"prefix":"10.1186","volume":"64","author":[{"given":"Homero","family":"Garcia-Motta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-0015","authenticated-orcid":false,"given":"Cristiano","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Maria","family":"Guilherme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Paulo Braz","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Nogueira Zambone Pinto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/acr.22721","volume":"68","author":"MG Cisternas","year":"2016","unstructured":"Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 2016;68:574\u201380. https:\/\/doi.org\/10.1002\/acr.22721.","journal-title":"Arthritis Care Res"},{"key":"364_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American college of rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72:149\u201362.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"364_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/rheumatology\/ket463","volume":"53","author":"SR Kingsbury","year":"2014","unstructured":"Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatol (United Kingdom). 2014;53:937\u201347. https:\/\/doi.org\/10.1093\/rheumatology\/ket463.","journal-title":"Rheumatol (United Kingdom)"},{"key":"364_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/ageing\/afw216","volume":"46","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Solmi M, Smith TO, Noale M, Cooper C, et al. Association between lower limb osteoarthritis and incidence of depressive symptoms: data from the osteoarthritis initiative. Age Ageing. 2017;46:470\u201376.","journal-title":"Age Ageing"},{"key":"364_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/acr.21617","volume":"64","author":"J Hermans","year":"2012","unstructured":"Hermans J, Koopmanschap MA, Bierma-Zeinstra SMA, Van Linge JH, Verhaar JAN, Reijman M, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res. 2012;64:853\u201361.","journal-title":"Arthritis Care Res"},{"key":"364_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","volume":"10","author":"DJ Hunter","year":"2014","unstructured":"Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10:437\u201341. https:\/\/doi.org\/10.1038\/nrrheum.2014.44.","journal-title":"Nat Rev Rheumatol"},{"key":"364_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.joca.2016.09.011","volume":"25","author":"B Sharif","year":"2017","unstructured":"Sharif B, Garner R, Hennessy D, Sanmartin C, Flanagan WM, Marshall DA. Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031. Osteoarthr Cartil. 2017;25:249\u201358. https:\/\/doi.org\/10.1016\/j.joca.2016.09.011.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18:476\u201399.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR9","doi-asserted-by":"publisher","unstructured":"Ghouri A, Conaghan PG. Prospects for therapies in osteoarthritis. Calcif Tissue Int. 2020. https:\/\/doi.org\/10.1007\/s00223-020-00672-9.","DOI":"10.1007\/s00223-020-00672-9"},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104:293\u2013311. https:\/\/doi.org\/10.1016\/j.mcna.2019.10.007.","journal-title":"Med Clin North Am"},{"key":"364_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0269215517691084","volume":"31","author":"L Brosseau","year":"2017","unstructured":"Brosseau L, Taki J, Desjardins B, Thevenot O, Fransen M, Wells GA, et al. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part two: strengthening exercise programs. Clin Rehabil. 2017;31:596\u2013611.","journal-title":"Clin Rehabil"},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","volume":"72","author":"L Fernandes","year":"2013","unstructured":"Fernandes L, Hagen KB, Bijlsma JWJ, Andreassen O, Christensen P, Conaghan PG, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72:1125\u201335.","journal-title":"Ann Rheum Dis"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"364_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/0269215517691085","volume":"31","author":"L Brosseau","year":"2017","unstructured":"Brosseau L, Taki J, Desjardins B, Thevenot O, Fransen M, Wells GA, et al. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part three: aerobic exercise programs *. Clin Rehabil. 2017;31:612\u201324.","journal-title":"Clin Rehabil"},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27:1578\u201389.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.29271\/jcpsp.2019.11.1067","volume":"29","author":"R Asjid","year":"2019","unstructured":"Asjid R, Faisal T, Qamar K, Malik S, Umbreen F, Fatima M. Effect of platelet-rich plasma on mankin scoring in chemically-induced animal model of osteoarthritis. J Coll Physicians Surg Pakistan. 2019;29:1067\u201371. https:\/\/doi.org\/10.29271\/jcpsp.2019.11.1067.","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"364_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-017-0521-3","volume":"12","author":"L Shen","year":"2017","unstructured":"Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12:1\u201312. https:\/\/doi.org\/10.1186\/s13018-017-0521-3.","journal-title":"J Orthop Surg Res"},{"key":"364_CR18","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1002\/jcp.28211","volume":"234","author":"D Fang","year":"2019","unstructured":"Fang D, Jin P, Huang Q, Yang Y, Zhao J, Zheng L. Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-\u03b2\/SMAD signaling pathway. J Cell Physiol. 2019;234:15627\u201337. https:\/\/doi.org\/10.1002\/jcp.28211.","journal-title":"J Cell Physiol"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000492415","volume":"59","author":"S Lang","year":"2018","unstructured":"Lang S, Loibl M, Herrmann M. Platelet-rich plasma in tissue engineering: hype and hope. Eur Surg Res. 2018;59:265\u201375. https:\/\/doi.org\/10.1159\/000492415.","journal-title":"Eur Surg Res"},{"key":"364_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tibtech.2006.02.010","volume":"24","author":"E Anitua","year":"2006","unstructured":"Anitua E, S\u00e1nchez M, Nurden AT, Nurden P, Orive G, And\u00eda I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227\u201334. https:\/\/doi.org\/10.1016\/j.tibtech.2006.02.010.","journal-title":"Trends Biotechnol"},{"key":"364_CR21","doi-asserted-by":"publisher","first-page":"065010","DOI":"10.1088\/1748-605X\/ab9e46","volume":"15","author":"G Irmak","year":"2020","unstructured":"Irmak G, G\u00fcm\u00fc\u015fderelio\u011flu M. Photo-activated platelet-rich plasma (PRP)-based patient-specific bio-ink for cartilage tissue engineering. Biomed Mater. 2020;15:065010. https:\/\/doi.org\/10.1088\/1748-605X\/ab9e46.","journal-title":"Biomed Mater"},{"key":"364_CR22","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1016\/j.biomaterials.2010.04.053","volume":"31","author":"FM Chen","year":"2010","unstructured":"Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials. 2010;31:6279\u2013308. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.04.053.","journal-title":"Biomaterials"},{"key":"364_CR23","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2106\/00004623-200206000-00022","volume":"84","author":"JR Lieberman","year":"2002","unstructured":"Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone biology and clinical applications. J Bone Jt Surg Ser A. 2002;84:1032\u201344. https:\/\/doi.org\/10.2106\/00004623-200206000-00022.","journal-title":"J Bone Jt Surg Ser A"},{"key":"364_CR24","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.joca.2006.05.008","volume":"14","author":"K Akeda","year":"2006","unstructured":"Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJMA, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil. 2006;14:1272\u201380.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR25","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2217\/rme-2020-0040","volume":"15","author":"MR Ahmad","year":"2020","unstructured":"Ahmad MR, Badar W, Ullah Khan MA, Mahmood A, Latif N, Iqbal T, et al. Combination of preconditioned adipose-derived mesenchymal stem cells and platelet-rich plasma improves the repair of osteoarthritis in rat. Regener Med. 2020;15:2285\u201395.","journal-title":"Regener Med"},{"key":"364_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6692432","volume":"2021","author":"GH Ragab","year":"2021","unstructured":"Ragab GH, Halfaya FM, Ahmed OM, Abou El-Kheir W, Mahdi EA, Ali TM, et al. Platelet-rich plasma ameliorates monosodium iodoacetate-induced ankle osteoarthritis in the rat model via suppression of inflammation and oxidative stress. Evid Based Complement Altern Med. 2021;2021:1\u201313.","journal-title":"Evid Based Complement Altern Med"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10047-014-0761-5","volume":"17","author":"S Kushida","year":"2014","unstructured":"Kushida S, Kakudo N, Morimoto N, Hara T, Ogawa T, Mitsui T, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014;17:186\u201392.","journal-title":"J Artif Organs"},{"key":"364_CR28","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.7248\/jjrhi.59.S59","volume":"59","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie J, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Aki EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Nihon Bika Gakkai Kaishi (Japanese J Rhinol). 2020;59:S59\u2013S61.","journal-title":"Nihon Bika Gakkai Kaishi (Japanese J Rhinol)"},{"key":"364_CR29","doi-asserted-by":"crossref","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.1. In: The Cochrane Collaboration. 2020.","DOI":"10.1002\/9781119536604"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u201326.","journal-title":"BMJ"},{"key":"364_CR31","doi-asserted-by":"publisher","unstructured":"Fabbri S, Silva C, Hernandes E, Octaviano F, Di Thommazo A, Belgamo A Improvements in the StArt tool to better support the systematic review process. Proceedings of the 20th international conference on evaluation and assessment in software engineering. New York, NY, USA: ACM; 2016. pp. 1\u20135. https:\/\/doi.org\/10.1145\/2915970.2916013","DOI":"10.1145\/2915970.2916013"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:1\u20139. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"key":"364_CR33","unstructured":"The Nordic Cochrane Centre TCCV 5.3.C. Revman 5 software. 2014."},{"key":"364_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"364_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.joca.2020.06.004","volume":"28","author":"P Jayaram","year":"2020","unstructured":"Jayaram P, Liu C, Dawson B, Ketkar S, Patel SJ, Lee BH, et al. Leukocyte-dependent effects of platelet-rich plasma on cartilage loss and thermal hyperalgesia in a mouse model of post-traumatic osteoarthritis. Osteoarthr Cartil. 2020;28:1385\u201393.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR36","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.3969\/j.issn.2095-4344.2015.38.012","volume":"19","author":"HD Ji","year":"2015","unstructured":"Ji HD, Huo XY, Zhang HQ, Wang YS, Shi X, Huo L. Platelet-rich plasma with sodium hyaluronate in repair of rabbit knee osteoarthritis. Chinese J Tissue Eng Res. 2015;19:6133\u201339. https:\/\/doi.org\/10.3969\/j.issn.2095-4344.2015.38.012.","journal-title":"Chinese J Tissue Eng Res"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.32098\/mltj.03.2017.04","volume":"07","author":"H Kanwat","year":"2019","unstructured":"Kanwat H, Mandeep Singh D, Devendra Kumar C, Alka B, Biman S, Aman H. The effect of intra-articular allogenic platelet rich plasma in Dunkin-Hartley guinea pig model of knee osteoarthritis. Muscle Ligaments Tendons J. 2019;07:426. https:\/\/doi.org\/10.32098\/mltj.03.2017.04.","journal-title":"Muscle Ligaments Tendons J"},{"key":"364_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.joms.2013.09.011","volume":"72","author":"N K\u00fct\u00fck","year":"2014","unstructured":"K\u00fct\u00fck N, Ba\u015f B, Soylu E, G\u00f6nen ZB, Yilmaz C, Balcio\u01e7lu E, et al. Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint. J Oral Maxillofac Surg. 2014;72:277\u201384.","journal-title":"J Oral Maxillofac Surg"},{"key":"364_CR39","first-page":"8562","volume":"13","author":"W Lu","year":"2020","unstructured":"Lu W, Zhang E, Liu D, Ruan B, Xie S. Effect of platelet-rich plasma on infection markers and jak\/stat pathway in rabbit models of knee osteoarthritis. Int J Clin Exp Med. 2020;13:8562\u201369. https:\/\/www.embase.com\/search\/results?subaction=viewrecord%26id=L2005531767%26from=export.","journal-title":"Int J Clin Exp Med"},{"key":"364_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.17221\/36\/2019-VETMED","volume":"65","author":"K Parlak","year":"2020","unstructured":"Parlak K, Arican M. Effect of intra-articular administration of autologous PRP and activated PRP on inflammatory mediators in dogs with osteoarthritis. Vet Med (Praha). 2020;65:62\u201370. https:\/\/doi.org\/10.17221\/36\/2019-VETMED.","journal-title":"Vet Med (Praha)"},{"key":"364_CR41","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/jor.23877","volume":"36","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhai C, Fei H, Hu J, Cui W, Wang Z, et al. Intraarticular injection autologous platelet-rich plasma and bone marrow concentrate in a goat osteoarthritis model. J Orthop Res. 2018;36:2140\u201346.","journal-title":"J Orthop Res"},{"key":"364_CR42","first-page":"21038","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu J, Zhang Z, Qin X, Cai X, Feng H. Platelet-rich-plasma alleviates pathological symptoms in a rabbit model of osteoarthritis. Int J Clin Exp Med. 2016;9:21038\u201347. http:\/\/www.embase.com\/search\/results?subaction=viewrecord%26from=export%26id=L613467865%0Ahttp:\/\/wt3cf4et2l.search.serialssolutions.com?sid=EMBASE%26issn=19405901%26id=doi:%26atitle=Platelet-rich-plasma+alleviates+pathological+symptoms+in+a+rabbit+model+of+osteoart.","journal-title":"Int J Clin Exp Med"},{"key":"364_CR43","doi-asserted-by":"publisher","unstructured":"Xin F, Wang H, Yuan F, Ding Y. Platelet-rich plasma combined with alendronate reduces pain and inflammation in induced osteoarthritis in rats by inhibiting the nuclear factor-kappa B signaling pathway. Biomed Res Int. 2020;2020. https:\/\/doi.org\/10.1155\/2020\/8070295.","DOI":"10.1155\/2020\/8070295"},{"key":"364_CR44","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.12659\/MSM.898218","volume":"22","author":"WJ Yin","year":"2016","unstructured":"Yin WJ, Xu HT, Sheng JG, An ZQ, Guo SC, Xie XT, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in treating rabbit knee osteoarthritis. Med Sci Monit. 2016;22:1280\u201390.","journal-title":"Med Sci Monit"},{"key":"364_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-016-0342-9","volume":"11","author":"S Yun","year":"2016","unstructured":"Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in Beagle dogs. J Orthop Surg Res. 2016;11:1\u201312. https:\/\/doi.org\/10.1186\/s13018-016-0342-9.","journal-title":"J Orthop Surg Res"},{"key":"364_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.aanat.2014.10.006","volume":"197","author":"SM Almasry","year":"2015","unstructured":"Almasry SM, Soliman HM, El-Tarhouny SA, Algaidi SA, Ragab EM. Platelet rich plasma enhances the immunohistochemical expression of platelet derived growth factor and vascular endothelial growth factor in the synovium of the meniscectomized rat models of osteoarthritis. Ann Anat. 2015;197:38\u201349. https:\/\/doi.org\/10.1016\/j.aanat.2014.10.006.","journal-title":"Ann Anat"},{"key":"364_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2754\/avb201887020127","volume":"87","author":"M Arican","year":"2018","unstructured":"Arican M, \u015eim\u015fek A, Parlak K, Atli K, S\u00f6nmez G. Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs. Acta Vet Brno. 2018;87:127\u201335. https:\/\/doi.org\/10.2754\/avb201887020127.","journal-title":"Acta Vet Brno"},{"key":"364_CR48","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1177\/0363546519856605","volume":"47","author":"DK Chouhan","year":"2019","unstructured":"Chouhan DK, Dhillon MS, Patel S, Bansal T, Bhatia A, Kanwat H. Multiple platelet-rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: an experimental study in a guinea pig model of early knee osteoarthritis. Am J Sports Med. 2019;47:2300\u201307. https:\/\/doi.org\/10.1177\/0363546519856605.","journal-title":"Am J Sports Med"},{"key":"364_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcms.2018.12.004","volume":"47","author":"U Coskun","year":"2019","unstructured":"Coskun U, Candirli C, Kerimoglu G, Taskesen F. Effect of platelet-rich plasma on temporomandibular joint cartilage wound healing: experimental study in rabbits. J Cranio-Maxillofacial Surg. 2019;47:357\u201364. https:\/\/doi.org\/10.1016\/j.jcms.2018.12.004.","journal-title":"J Cranio-Maxillofacial Surg"},{"key":"364_CR50","doi-asserted-by":"publisher","first-page":"554","DOI":"10.21608\/ejh.2019.9750.1090","volume":"42","author":"N Gamal","year":"2019","unstructured":"Gamal N, Abou-Rabia NM, El Ebiary FH, Khalaf G, Raafat MH. The possible therapeutic role of platelet rich plasma on a model of osteoarthritis in male albino rat. Histological and immunohistochemical study. Egypt J Histol. 2019;42:554\u201366. https:\/\/doi.org\/10.21608\/ejh.2019.9750.1090.","journal-title":"Egypt J Histol"},{"key":"364_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1076029612452117","volume":"19","author":"S Guner","year":"2013","unstructured":"Guner S, Buyukbebeci O. Analyzing the effects of platelet gel on knee osteoarthritis in the rat model. Clin Appl Thromb. 2013;19:494\u201398. https:\/\/doi.org\/10.1177\/1076029612452117.","journal-title":"Clin Appl Thromb"},{"key":"364_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr.15038569","volume":"15","author":"LC Hermeto","year":"2016","unstructured":"Hermeto LC, DeRossi R, Oliveira RJ, Pesarini JR, Antoniolli-Silva ACMB, Jardim PHA, et al. Effects of intra-articular injection of mesenchymal stem cells associated with platelet-rich plasma in a rabbit model of osteoarthritis. Genet Mol Res. 2016;15:1\u201314.","journal-title":"Genet Mol Res"},{"key":"364_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/jor.1100100107","volume":"10","author":"JA van der Sluijs","year":"1992","unstructured":"van der Sluijs JA, Geesink RGT, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the mankin score for osteoarthritis. J Orthop Res. 1992;10:58\u201361. https:\/\/doi.org\/10.1002\/jor.1100100107.","journal-title":"J Orthop Res"},{"key":"364_CR54","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/art.11014","volume":"48","author":"JP Pelletier","year":"2003","unstructured":"Pelletier JP, Fernandes JC, Brunet J, Moldovan F, Schrier D, Flory C, et al. In vivo selective inhibition of mitogen-activated protein kinase kinase 1\/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. Arthritis Rheum. 2003;48:1582\u201393.","journal-title":"Arthritis Rheum"},{"key":"364_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KPH Pritzker","year":"2006","unstructured":"Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell K, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14:13\u201329.","journal-title":"Osteoarthr Cartil"},{"key":"364_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325967120973284","volume":"9","author":"LY Nie","year":"2021","unstructured":"Nie LY, Zhao K, Ruan J, Xue J. Effectiveness of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled clinical trials. Orthop J Sport Med. 2021;9:1\u201311. https:\/\/doi.org\/10.1177\/2325967120973284.","journal-title":"Orthop J Sport Med"},{"key":"364_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10067-020-05185-2","volume":"40","author":"Y Dong","year":"2021","unstructured":"Dong Y, Zhang B, Yang Q, Zhu J, Sun X. The effects of platelet-rich plasma injection in knee and hip osteoarthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2021;40:263\u201377. https:\/\/doi.org\/10.1007\/s10067-020-05185-2.","journal-title":"Clin Rheumatol"},{"key":"364_CR58","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1001\/jama.2021.19415","volume":"326","author":"KL Bennell","year":"2021","unstructured":"Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA. 2021;326:2021\u201330.","journal-title":"JAMA"},{"key":"364_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-021-04706-7","volume":"22","author":"M D\u00f3rio","year":"2021","unstructured":"D\u00f3rio M, Pereira RMR, Luz AGB, Deveza LA, de Oliveira RM, Fuller R. Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial. BMC Musculoskelet Disord. 2021;22:1\u201312. https:\/\/doi.org\/10.1186\/s12891-021-04706-7.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-024-00364-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T08:54:11Z","timestamp":1722243251000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-024-00364-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s42358-024-00364-0","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study, as the data used comprises of peer-reviewed publications and information that could identify the subjects of the original studies was not included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}